FDA Grants ODD to Maia Biotechnology for Glioblastoma Treatment

Retrieved on: 2023-11-15 13:56:22

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants ODD to Maia Biotechnology for Glioblastoma Treatment. View article details on HISWAI: https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/fda-grants-odd-to-maia-biotechnology-for-glioblastoma-treatm/

Excerpt

MAIA Biotechnology have announced that the U.S. Food and Drug Administration has granted orphan drug designation to its lead asset THIO, ...

Article found on: pharmaceuticalmanufacturer.media

View Original Article